12.02.24 -- Drug Device Availability, Sustainability, And Integrity With Windgap Medical

Whether bringing a novel therapy to market or altering current devices, companies must determine the best selection for administration without impacting drug efficacy, quality, and safety.

Explore the challenges to effective delivery of drugs to the eye, intricacies of ophthalmic drug delivery, and advantages of nanoparticles as an enabling technology for ocular drug-delivery systems.

Learn how to expedite the development pathway for early phase compounds and how lipid based formulations provide an innovative approach to enhance bioavailability for challenging molecules.

Here, we compare three combination case studies, in which bevacizumab is paired with erlotinib, cisplatin, or paclitaxel in a dry powder inhaler formulation.

Review a commercially-ready process capable of reproducing spray-dried dispersions with less manufacturing complexity and environmental impact, and out-designing and outperforming spray drying.

A TheraPEA polymer-based injectable formulation designed to deliver the same dose of Triamcinolone Acetonide (TAA) as in Zilretta has shown promising results in a series of pre-clinical studies.